J. Mckoy

J. Mckoy, N. Gilmore, J. Schumacher, 2022, American Society of Clinical Oncology educational book. American Society of Clinical Oncology. Annual Meeting.

Survivorship care planning in a comprehensive cancer center using an implementation framework.

F. Penedo, J. Mckoy, S. Garcia, 2016, The Journal of community and supportive oncology.

Anticancer drug use in geriatric patients: concerns and challenges.

Denys T. Lau, J. Mckoy, Mary Jarzebowski, 2011, Clinical therapeutics.

Evaluation of a Potential Clinical Interaction between Ceftriaxone and Calcium

P. Yarnold, M. Postelnick, C. Bennett, 2010, Antimicrobial Agents and Chemotherapy.

Cancer Drug Toxicity: Moving from Patient to Survivor.

J. Mckoy, Megan Slocum, S. García, 2018, Cancer treatment and research.

NCCN Guidelines ® Insights Older Adult Oncology, Version 2.2016 Featured Updates to the NCCN Guidelines

H. Cohen, C. Gross, R. Jagsi, 2016 .

Reassessments of ESAs for cancer treatment in the US and Europe.

J. Armitage, I. Macdougall, C. Bennett, 2010, Oncology.

Malnutrition in older patients with cancer: Appraisal of the Mini Nutritional Assessment, weight loss, and body mass index.

V. Valero, C. Dinney, D. Tripathy, 2018, Journal of geriatric oncology.

Breakthrough zygomycosis after voriconazole administration among patients with hematologic malignancies who receive hematopoietic stem-cell transplants or intensive chemotherapy

J. Mehta, P. Yarnold, F. Palella, 2007, Bone Marrow Transplantation.

Systematic Review of Piperacillin-Induced Neutropenia

P. Yarnold, B. Djulbegovic, F. Palella, 2007, Drug safety.

Long-term outcome of individuals with pure red cell aplasia and antierythropoietin antibodies in patients treated with recombinant epoetin: a follow-up report from the Research on Adverse Drug Events and Reports (RADAR) Project.

S. Belknap, P. Yarnold, A. Nissenson, 2005, Blood.

FDA Policies Should Be Amended To Allow Pharmaceutical Manufacturers To Disseminate Information Regarding Potentially Fatal Toxicities That Occur with Off-Label Use of Oncology Agents: A Policy Recommendation Based on Review of Thalidomide-Associated Thromboembolism Cases by the RADAR Project.

S. Singhal, J. Mehta, P. Yarnold, 2004 .

Accelerated FDA Approval of Drugs Used To Treat Hematologic Malignancies: Are Policy Changes Needed?.

S. Belknap, C. Bennett, J. Mckoy, 2004 .

Gemtuzumab ozogamicin (GO)-associated veno-occlusive disease (VOD): An analysis of adverse drug reaction (ADR) reports in the clinical trials, clinical practice, and in the medical literature

P. Yarnold, C. Bennett, J. Mckoy, 2004 .

Completeness and effectiveness of reporting on three drugs: Lessons learned from RADAR, a novel pharmacosurveillance and pharmacovigilance program

S. Belknap, C. Bennett, J. Mckoy, 2004 .

Report card for accelerated FDA approval oncology drugs (1995- 2003): Is it time for a make-up test?

S. Belknap, C. Bennett, J. Mckoy, 2004, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Davids versus Goliaths: Pharma and academia threats to individual scientists and clinicians

Benjamin L. Schooley, J. Mckoy, W. Hrushesky, 2022, The Journal of Scientific Practice and Integrity.

Costs and cost effectiveness of a health care provider-directed intervention to promote colorectal cancer screening.

J. Graff Zivin, C. Bennett, J. Mckoy, 2009, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Bisphosphonate use and osteonecrosis of the jaw: Pharmacovigilance and reporting of this serious adverse event from the Research on Adverse Drug Events and Reports (RADAR) project

M. Dimopoulos, M. Gounder, C. Bennett, 2007 .

AIs: implications for fractures in perimenopausal women with breast cancer.

C. Bennett, J. Mckoy, B. Edwards, 2008, Community oncology.

Clopidogrel-associated TTP: The next chapter

C. Bennett, J. Mckoy, T. Luu, 2008 .

Progressive multifocal leukoencephalopathy following rituximab treatment

C. Bennett, J. Mckoy, M. Frick, 2009 .

Providing cancer care to a graying and diverse cancer population in the 21st century: are we prepared?

C. Bennett, J. Mckoy, A. Samaras, 2009, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Biosimilars: Are They Really Safe?

J. Mckoy, F. Giles, 2018, Cancer treatment and research.

Hematologic malignancy risk with granulocyte colony-stimulating factors

C. Bennett, J. Mckoy, C. Angelotta, 2007 .

Hepatotoxicity Associated with Long-versus Short-Course HIV-Prophylactic Nevirapine Use

P. Yarnold, F. Palella, C. Bennett, 2009, Drug safety.

Legal, financial, and public health consequences of transfusion‐transmitted hepatitis C virus in persons with haemophilia

C. Buffie, C. Bennett, J. Mckoy, 2007, Vox sanguinis.

Ticlopidine‐associated ADAMTS13 activity deficient thrombotic thrombocytopenic purpura in 22 persons in Japan: a report from the Southern Network on Adverse Reactions (SONAR)

T. Ortel, J. Mckoy, W. Clark, 2013, British journal of haematology.

Senior adult oncology, version 2.2014: clinical practice guidelines in oncology .

H. Cohen, R. Jagsi, N. Keating, 2014, Journal of the National Comprehensive Cancer Network : JNCCN.

Caveat patiens — ethical dilemmas in decision -making

J. Mckoy, J. Mckoy, Judith M McKoy, 2008 .

Reporting of serious adverse events during cancer clinical trials to the institutional review board: An evaluation by the Research on Adverse Drug events And Reports (RADAR) project

S. Weitzman, S. Belknap, D. West, 2013, Journal of clinical pharmacology.

Results from the First Decade of Research Conducted by the Research on Adverse Drug Events and Reports (RADAR) Project

S. Belknap, D. Courtney, B. Nardone, 2013, Drug Safety.

Senior Adult OncologyPractice Guidelines in Oncology

H. Cohen, J. Holland, N. Keating, 2012 .

Identifying Geriatric Oncology Competencies for Medical Oncology Trainees: A Modified Delphi Consensus Study.

J. Mckoy, I. Parker, A. Gajra, 2020, The oncologist.

Pure red-cell aplasia and epoetin therapy.

Allen R Nissenson, Stefano Luminari, Benjamin Kim, 2004, The New England journal of medicine.

Gemtuzumab ozogamicin-associated sinusoidal obstructive syndrome (SOS): an overview from the research on adverse drug events and reports (RADAR) project.

C. Bennett, J. Mckoy, C. Angelotta, 2007, Leukemia research.

Granulocyte-colony stimulating factor administration to healthy individuals and persons with chronic neutropenia or cancer: an overview of safety considerations from the Research on Adverse Drug Events and Reports project

C. Bennett, C. C. Tigue, J. Mckoy, 2007, Bone Marrow Transplantation.

A retrospective multicenter analysis of elderly Hodgkin lymphoma: outcomes and prognostic factors in the modern era.

Scott E. Smith, Sonali M. Smith, L. Gordon, 2012, Blood.

Amiodarone-associated optic neuropathy: a critical review.

R. Passman, S. Belknap, D. West, 2012, The American journal of medicine.

Clopidogrel-Associated TTP: An Update of Pharmacovigilance Efforts Conducted by Independent Researchers, Pharmaceutical Suppliers, and the Food and Drug Administration

P. Gorelick, P. Yarnold, D. Pandey, 2004, Stroke.

Health Equity for Older Adults With Cancer.

J. Mckoy, Sherrie F Wallington, B. Canin, 2021, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Acute kidney injury and bisphosphonate use in cancer: a report from the research on adverse drug events and reports (RADAR) project.

S. Belknap, D. West, J. Mckoy, 2013, Journal of oncology practice.

NCCN Guidelines® Insights: Older Adult Oncology, Version 1.2021.

H. Cohen, C. Gross, R. Jagsi, 2021, Journal of the National Comprehensive Cancer Network : JNCCN.

Hypersensitivity cases associated with drug-eluting coronary stents: a review of available cases from the Research on Adverse Drug Events and Reports (RADAR) project.

Matthew H Samore, Jonathan R Nebeker, Marc D Feldman, 2006, Journal of the American College of Cardiology.

Senior adult oncology.

H. Cohen, J. Holland, N. Keating, 2012, Journal of the National Comprehensive Cancer Network : JNCCN.

Analysis of very elderly (≥80 years) non‐hodgkin lymphoma: impact of functional status and co‐morbidities on outcome

Scott E. Smith, Sonali M. Smith, J. Mckoy, 2012, British journal of haematology.

Impact of United States Food and Drug Administration's boxed warnings on adverse drug reactions reporting rates and risk mitigation for multiple myeloma drugs

S. Belknap, D. West, B. Nardone, 2013, Expert opinion on drug safety.

Anaphylaxis associated with gadolinium-based contrast agents: data from the Food and Drug Administration's adverse event reporting system and review of case reports in the literature

D. West, F. Miller, B. Nardone, 2014, Expert Opinion on Drug Safety.

Granulocyte colony-stimulating factor for chemotherapy-induced neutropenia in patients with small cell lung cancer

J. Mckoy, G. Schumock, K. Fitzner, 2005, PharmacoEconomics.

Cancer Policy: Pharmaceutical Safety

D. West, J. Mckoy, S. Rosen, 2019, Cancer Treatment and Research.

Cost considerations in the management of cancer in the older patient.

C. Bennett, C. C. Tigue, J. Mckoy, 2007, Oncology.

Haematological malignancies developing in previously healthy individuals who received haematopoietic growth factors: report from the Research on Adverse Drug Events and Reports (RADAR) project

P. Bierman, J. Vose, J. Mckoy, 2006, British journal of haematology.

Patient preferences in prostate cancer: a clinician's guide to understanding health utilities.

M. Wolf, C. Bennett, J. Mckoy, 2005, Clinical prostate cancer.

Community-Driven Conversations: Partnership Building through CHEC-Ins

J. Mckoy, R. Warnecke, Melissa A. Martinez, 2023, Progress in Community Health Partnerships: Research, Education, and Action.

Community-Academic Partnerships to Reduce Cancer Inequities: The ChicagoCHEC Community Engagement Core

J. Mckoy, Moira E. Stuart, Sha Wang, 2019, Progress in community health partnerships : research, education, and action.

Adverse Drug Interactions

C. Bennett, J. Mckoy, T. Luu, 2010, PharmacoEconomics.

Reducing the risks of diabetes complications through diabetes self-management education and support.

S. Boren, J. Mckoy, D. Sherr, 2013, Population health management.

Epoetin‐associated pure red cell aplasia: past, present, and future considerations

Allen R Nissenson, Dennis W Raisch, A. Nissenson, 2008, Transfusion.

NCCN: Continuing Education

H. Cohen, C. Gross, R. Jagsi, 2021 .

Quality of Reporting of Serious Adverse Drug Events to an Institutional Review Board: A Case Study with the Novel Cancer Agent, Imatinib Mesylate

S. Weitzman, D. Dorr, S. Belknap, 2009, Clinical Cancer Research.

Sepsis in Older Adults.

J. Mckoy, T. Rowe, J. McKoy, 2017, Infectious disease clinics of North America.

Consequences to patients, clinicians, and manufacturers when very serious adverse drug reactions are identified (1997–2019): A qualitative analysis from the Southern Network on Adverse Reactions (SONAR)

Benjamin L. Schooley, Matthew A. Taylor, P. Yarnold, 2020, EClinicalMedicine.

and Reports (RADAR) Project epoetin: a follow-up report from the Research on Adverse Drug Events antierythropoietin antibodies in patients treated with recombinant Long-term outcome of individuals with pure red cell aplasia and

S. Belknap, P. Yarnold, A. Nissenson, 2013 .

Two mechanistic pathways for thienopyridine-associated thrombotic thrombocytopenic purpura: a report from the SERF-TTP Research Group and the RADAR Project.

P. Yarnold, C. Buffie, T. Ortel, 2007, Journal of the American College of Cardiology.

Bisphosphonates and nonhealing femoral fractures: analysis of the FDA Adverse Event Reporting System (FAERS) and international safety efforts: a systematic review from the Research on Adverse Drug Events And Reports (RADAR) project.

S. Belknap, D. West, D. Rao, 2013, The Journal of bone and joint surgery. American volume.

Is ethics for sale?... Juggling law and ethics in managed care.

M. Wynia, J. Mckoy, Kari L. Karsjens, 2005, DePaul journal of health care law.

Elevated incidence of fractures in women with invasive breast cancer

A. Rademaker, W. Gradishar, D. West, 2016, Osteoporosis International.

Racial Variations in Care and Outcomes for Inpatient HIV-Related Pneumocystis Pneumonia

J. Chmiel, P. Yarnold, R. Weinstein, 2010, Journal of health care for the poor and underserved.

Cancer Therapy Associated Bone Loss: Implications for Hip Fractures in Mid-Life Women with Breast Cancer

W. Gradishar, D. West, C. Bennett, 2011, Clinical Cancer Research.

Opportunities for disease state management in prostate cancer.

A. Pickard, C. Bennett, J. Mckoy, 2005, Disease management : DM.

Temporal Lobe Epilepsy Masquerading as Dementia

J. Mckoy, June M. McKoy, Andrew Thurston, 2012, Journal of the American Geriatrics Society.

Fluoroquinolone-associated tendon-rupture: a summary of reports in the Food and Drug Administration’s adverse event reporting system

C. Bennett, J. Mckoy, D. Raisch, 2015, Expert opinion on drug safety.

Costs and outcomes evaluation of patient navigation after abnormal cancer screening: Evidence from the Patient Navigation Research Program

K. Fiscella, E. Seiber, S. Ramsey, 2014, Cancer.

Accelerated approval of cancer drugs: improved access to therapeutic breakthroughs or early release of unsafe and ineffective drugs?

Steven Hirschfeld, Jonathan R Nebeker, Kenneth R Carson, 2009, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Bevacizumab-associated diverticulitis

D. Courtney, C. Bennett, J. Mckoy, 2008 .

Evaluating the cost‐effectiveness of cancer patient navigation programs: Conceptual and practical issues

Kevin Fiscella, Scott Ramsey, K. Fiscella, 2009, Cancer.

Psychometric development and reliability analysis of a patient satisfaction with interpersonal relationship with navigator measure: a multi‐site patient navigation research program study

P. Jean-Pierre, K. Fiscella, J. Mckoy, 2012, Psycho-oncology.

Costs and cost effectiveness of a health care provider-directed intervention to promote colorectal cancer screening among Veterans.

M. Wolf, C. Bennett, J. Mckoy, 2005, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Effects of cancer comorbidity on disease management: making the case for diabetes education (a report from the SOAR program).

J. Mckoy, B. Edwards, K. Fitzner, 2013, Population health management.

Costs and cost-effectiveness of a low-intensity patient-directed intervention to promote colorectal cancer screening.

C. Bennett, J. Mckoy, N. Nonzee, 2007, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

A tale of two citizens: a State Attorney General and a hematologist facilitate translation of research into US Food and Drug Administration actions--a SONAR report.

S. Xirasagar, C. Bennett, J. Mckoy, 2012, Journal of oncology practice.

Ambulatory and Outpatient Care

J. Mckoy, T. Rowe, Alisha Gupta, 2019, Encyclopedia of Gerontology and Population Aging.

Assessing cognitive function and capacity in older adults with cancer.

J. Mckoy, R. Rupper, I. Browner, 2014, Journal of the National Comprehensive Cancer Network : JNCCN.

Cancer Comorbidity: Implications for Drug Safety.

F. Penedo, J. Mckoy, K. O’Brien, 2018, Cancer treatment and research.

Granulocyte colony--stimulating factor for chemotherapy-induced neutropenia in patients with small cell lung cancer : the 40% rule revisited.

C. Bennett, J. Mckoy, G. Schumock, 2005, PharmacoEconomics.